posted on 2020-11-04, 04:28authored byP. P. J. Phillips, A. Van Deun, S. Ahmed, R. L. Goodall, S. K. Meredith, F. Conradie, C-Y Chiang, I. D. Rusen, A. J. Nunn
Additional file 1. Contains supplementary methods describing the Week 132 outcome (alternative outcome E), a comparison of the five alternative outcomes (Table S1), and sensitivity analyses for the FoR analysis in more detail. Also includes supplementary results in Table S2. Summary of secondary efficacy outcomes by treatment arm in MITT analysis population.
Funding
United States Agency for International Development Medical Research Council Department for International Development